MANDY XI: Open Payments
NPI 1669940896 · STATEN ISLAND, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$478 in 12 payments from 9 companies in 2025. Trend: 2023 $31 · 2024 $386 · 2025 $478
Food & beverage: $433Education: $45
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $125 |
| Gilead Sciences, Inc. | 3 | $58 |
| Lilly USA, LLC | 1 | $45 |
| GlaxoSmithKline, LLC. | 2 | $43 |
| Corcept Therapeutics | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| Exact Sciences Corporation | 1 | $20 |
| Novo Nordisk Inc | 1 | $16 |
Products named: AIRSUPRA, JARDIANCE, SHINGRIX, Korlym, REXULTI, Cologuard Collection Kit.
Industry payments across NY — which companies pay providers there.
